Featuring slide presentations and related discussion from Dr Emmanuel S Antonarakis, Ms Jamie Carroll, Ms Erika Meneely, Dr Kathleen Moore, Dr Joyce O’Shaughnessy, Dr Michael J Pishvaian, Ms Tammy Triglianos and Ms Deborah Wright. (Video Program)

Proceedings from the tenth in a series of 11 integrated webinars held in association with the 2020 ONS Annual Congress. Featuring perspectives from Dr Emmanuel S Antonarakis, Ms Gretchen Santos Fulgencio, Dr Kathleen Moore, Dr Joyce O’Shaughnessy, Dr Michael J Pishvaian and Ms Deborah Wright. (Audio Program)

Proceedings from the tenth in a series of 11 integrated webinars held in association with the 2020 ONS Annual Congress. Featuring perspectives from Dr Emmanuel S Antonarakis, Ms Gretchen Santos Fulgencio, Dr Kathleen Moore, Dr Joyce O’Shaughnessy, Dr Michael J Pishvaian and Ms Deborah Wright. (Video Program)

New Agents and Strategies in the Management of Multiple Myeloma is a unique CME activity that attempts to review key clinical questions regarding the integration of newly FDA-approved therapies in multiple myeloma into oncology practice. Featuring commentary from Drs Morie A Gertz and Andrzej J Jakubowiak. (Text Content)

Featuring interviews with Drs Keith T Flaherty, Charles S Fuchs, Eric P Winer, Daniel J George, Edward S Kim, A Keith Stewart, Jonathan W Friedberg, Hagop M Kantarjian and Jonathan A Ledermann. (Audio Content)

This series of activities is comprised of abbreviated slide sets along with edited commentary from clinical investigators summarizing the significance of results presented at the ASCO 2011 Annual Meeting. Solid tumors that are highlighted include melanoma, GIST and breast, lung, ovarian, colorectal and genitourinary cancers. Hematologic cancers and related disorders that are highlighted include acute and chronic lymphoid and myeloid leukemias, myelodysplastic syndromes, myelofibrosis, multiple myeloma and diffuse large B-cell lymphoma.

Featuring interviews with Drs Robert Z Orlowski and Hyman B Muss. (Audio Content)